CrossrefInfokarte
Effect of Sotagliflozin on Kidney Function and Cardio‐Kidney‐Metabolic Parameters Across Baseline eGFR Subgroups in Patients With Type 2 Diabetes and Stage 4 CKD
Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11966-11970
DOI: 10.1111/dom.71256 ↗Abstract
Kein Abstract verfügbar.
EUVIMED